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INTRODUCTION
CANCER CERVIX:
Of all  the  responsibilities  of  the  gynaecologist  in  modern  world  perhaps  none  is  as 
important  as the detection of neoplasia at the earliest.   Cancer cervix is the most common 
cancer  in  women in  the  developing countries   & second most  common form of  cancer  in 
women throughout the world.
Approximately 16,000 new cases of cervical cancer are diagnosed each year.  About 
4,800 women die from this disease annually.  The 5 years survival rate is 90% for localized 
cervical cancer and it is considerably lower (14%) for persons with advanced stage IV disease. 
The incidence of invasive cervical cancer has decreased significantly over the last 40 years, 
mainly because of early detection programs.
Although all sexually active women are at risk for cervical cancer, the disease is more 
common among women of  low socioeconomic  status,  those  with  multiple  sexual  partners, 
smokers and those with HPV infection.4
INCIDENCE
Among the total incidence of cancer cervix 78% occur the developing countries (15% of 
Female Malignancies). 
In the developing countries the incidence is 12 per 100,000 women and in the developed 
countries it is 7.6 per 100,000.4
PREVALENCE
A conservative estimate of global prevalence based upon 2000 data suggests that there are 
nearly  1.4  million  cases  of  clinically  recognized  cervical  cancer  (based  on  the  number  of 
patients still alive five years after diagnosis).1  The vast majority of these cases occurred in 
developing countries. This estimate reflects the accumulation of cases each year and the fact 
that few women in developing countries receive treatment. Current knowledge of the natural 
history of cervical cancer suggests that two to five times as many women may have potential 
precursor  conditions  of  cervical  cancer  as  have  invasive  cancer.  Therefore,  as  many  as 
7,000,000 women worldwide may have  high-grade  dysplasia  that  should  be  identified and 
treated.
                 Existing estimates of cervical cancer incidence, prevalence, and mortality probably 
are lower than actual rates, largely because many women
with cervical cancer do not receive medical care and thus are not included in cancer registry 
data. Limitations of diagnostic facilities and their tendency not to reach older women, those 
with  late-stage  illness,  or  those  unable  to  pay  for  services  present  further  challenges  to 
developing accurate estimates. In addition, the lack of organized health information systems 
makes recording the number of women with cervical cancer problematic.4
SCREEENING FOR CANCER CERVIX
Routine screnning for cervical cancer with papanicolaou  (pap) testing is recommended 
for all women who are or have been sexually active.  Now screening using visual inspection of 
cervix is being recommended especially is low resource countries like India.
In  India  the  number  of  trained  cytopathologist  is  minimal  even  with  a  twelve  fold 
increase in these staff only 25% of women over 35 years could be screened therefore there is a 
distinct need for alternate strategy to detect cancer cervix at an earlier stage.4
One Such Strategy – Visual Screening, in asymptomatic women so as to detect cancer cervix 
– in early stages. Visual inspection consists of down staging and aided visual inspection.
OTHER OPTIONS
1. Cervicography
2. Colposcopy.
3. Automated pap tests
4. Molecular HPV –DNA Studies.
Down staging   
Just simple speculum examination done to identify early abnormal change 
on the cervix.
Aided Visual Inspection
Either Magnification or Chemical enhancement with acetic acid and lugol’s iodine.
               SOME OF THE VISUAL INSPECTION STUDIES 
1.Test characteristic of visual inspection with 4% acetic acid (VIA) and lugol’s iodine (VILI) in 
cervical cancer screening in kerala, India by SANKARANARAYANAN. R
4444 women
25 yrs to 60 yrs
Kerala, India.
All patients were subjected to VIA ;VILI;PAP SMEAR CYTOLOGY & positive cases were 
subjected  to  biopsy.  Based  on  the  results  VIA  &  VILI  were  considered  to  be  suitable 
alternative screening test to cytology for detecting cervical  neoplasia in low resource settings.26
2.  Visual inspection with acetic acid and cytology in early detection of cervical neoplasia., 
Kolkata,  India.SANKARANARANAN  (in collaboration with Calcutta  cervical  cancer  early 
detection group).
5881 Women
30-64 Years
Screened by VIA /VIAM/Cytology.
Positive cases were subjected to biopsy.
18.7 %, 17 %, 8.2% tested positive for VIA, VIAM, Cytology respectively.
They concluded that VIA & VIAM had significantly higher sensitivity than cytology.26
My Study is based on the evidences provided by the above studies
AIM OF STUDY
This study aims at detecting the efficacy of Visual Inspection with Acetic acid (VIA) & 
Visual Inspection with Lugol’s Iodine (VILI) in the early detection of cancer cervix.
          The relative efficacy of these two methods is compared with pap smear & cervical 
biopsy,  to  choose  an  easily  interpretable  low  cost  but  equally  effective  method  for  early 
detection of cancer cervix .
REVIEW OF LITERATURE
The highest age-standardized incidence rates of cervical cancer have been reported in  Asia, 
Southern Africa, Central America, Eastern Africa, and South America An important reason for 
the  high  cervical  cancer  incidence  in  developing  countries  in  comparison  to  developed 
countries  is  the  lack  of  effective  screening  programs  aimed  at  detecting  precancerous 
conditions and treating them before they progress to invasive cancer. A 1985 estimate indicated 
that only about five percent of women in developing countries had been screened for cervical 
neoplasia in the previous five years, compared with 40 to 50 percent of women in developed 
countries.5  It  is  unlikely  that  this  disparity  has  changed  significantly.  Lack  of  access  to 
screening compounds the effect of high rates of human papillomavirus (HPV) infection, are the 
primary underlying cause of cervical cancer.
The 2000 estimate of global cervical cancer incidence is over 25 percent higher  than the 1990 
estimate.
In 1851,  Robert Hull, introduced the use of vaginal speculum which revealed an epidemic of uterine 
disease.  The existence  of preinvasive stage in the development of cervical cancer has been known. 
Since Sir John Williams in the Haverian lectures in  (1886) presented  a case of symptomless cancer 
cervix (known as carcinorma in situ, now). Papanicolaou & Traut first reported the use of exfoliative 
cervical  cytology for  the  diagnosis  of  cervical  cancer  & precancer  (1945)  and  the  technique  was 
improved  with  Ayre’s  wooden spaluta.   Hinselmann in Germany  first  published  an  account  of 
colposcopy in 1925. It has become possible to observe cancer at its very earliest stage.Boys & Worth 
(1979) declared that introduction of cytological screening for cancer cervix in developing countries 
reduced the morbidity & mortality of cancer cervix.
           The first cervical cancer prevention programs were based on the premise that the disease 
developed from precursor lesions (broadly known as dysplasia), progressing steadily from mild 
to moderate to severe dysplasia to
carcinoma in situ (CIS), and then to cancer. In fact, it now appears that the direct precursor to 
cervical cancer is high-grade dysplasia, which can progress to cervical cancer over a period of 
up to 10 years .Most lower-grade dysplasia regresses or does not progress, particularly lower-
grade incident cases in younger women (aged 34 or less). 
Cervical Screening Recommendations 1988 and 2002-2003 9
1988 Consensus 
Guidelines 27
2002 ACS 
Guidelines 36
2003 ACOG 
Guidelines 37
2003 USPSTF 
Guidelines 38
When to start 
screening
Age 18 or with 
onset of sexual 
intercourse
Age 21 or 
about 3 yrs 
after onset of 
vaginal 
intercourse
Age 21 or 
about 3 yrs 
after onset of 
vaginal 
intercourse  
Age 21 or 
about 3 yrs 
after onset of 
vaginal 
intercourse
Screening 
Interval
Annually until 3 
consecutive 
satisfactory 
negatives then 
interval may be 
extended at the 
discretion of 
provider
Annually unitl 
age 30, 
Biennially if 
liquid based 
cytology used
Annually until 
age 30 using 
either 
conventional 
or liquid based 
cytology
Every 3 yrs
Age 30 or 
older after 3 
consecutive 
satisfactory 
negatives may 
Age 30 or 
older after 3 
consecutive 
satisfactory 
negatives and 
screen every 
2-3 yrs
no history of 
CIN 2 or 3 
may screen 
every 2-3 yrs
When to stop 
screening
No upper limit Age 70 in well 
screened, low 
risk women
Evidence 
inconclusive 
to set upper 
age
Age 65 in well 
screened, low 
risk women
Post 
hysterectomy
No 
recommendations
Screening not 
recommended 
after 
hysterectomy 
for benign 
indications if 
cervix 
removed if no 
prior CIN 2 or 
3
Screening not 
recommended 
after 
hysterectomy 
for benign 
indications if 
cervix 
removed if no 
prior CIN 2 or 
3
Discontinue 
screening after 
hysterectomy 
if no evidence 
of cervical 
neoplasia or 
cancer
Screening: Visual Approaches
         Considerable  research  has  been  undertaken recently  to  explore  the  accuracy  and 
acceptability of visual inspection as a means of detecting pre-cursor cervical disease and/or 
cancer.  Visual  screening  is  a  process  of  identifying  cervical  lesions  without  reliance  on 
cytology (Pap smears). There are several types of visual screening. Early studies utilized visual 
inspection (VI), which involved simply looking at the cervix with the unaided eye for any signs 
of early cancer. Also known as “downstaging,” this approach was not accurate in identifying 
precancerous conditions.4
Visual inspection with acetic acid (VIA) is considered a more promising screening approach 
for identifying precancerous lesions.
        This screening approach involves swabbing the cervix with an acetic acid solution prior to 
visual  examination.  Differences  in  precancerous  cell  structure  and  absorption  rates  make 
abnormal cells temporarily turn white when exposed to this solution. Alternatively, some visual 
screening approaches have used the application of an iodine-based solution (Lugol’s solution) 
as a means of staining normal cervical cells brown, leaving the abnormal cells with a yellow or 
unstained appearance.20
          In general, the sensitivity of VIA in detecting high-grade dysplasia is at least equal to 
that of cytology, while VIA's specificity is somewhat lower. The feasibility of utilizing VIA for 
wide-scale screening  to a large extent will be determined by the effectiveness of training and 
monitoring efforts. VIA shows promise as an option for identifying precancerous lesions in 
many settings, either in conjunction with or as an alternative to other screening approaches.
Technology used for visual screening methods 9
Term used for method Magnification Enhancement
Schiller test 
Lugol’s Iodine test
Visual inspection with 
Lugol’s iodine
No Iodine Staining
Downstaging No No
Direct visual inspection No 3% - 5% acetic acid 
solution
Acetic acid washes
Acetic acid visualization
Acetic acid screening test
Visual inspection with 
acetic acid cervicoscopy
Acetic acid test
Aided visual inspection
Gynoscopy
2.5 –4 x 3% - 5% acetic acid 
solution
Avioscopy
DVI with magnification
Visual inspection with 
acetic acid and 
magnification
Speculoscopy 4-6 x magnification 3% - 5% acetic acid 
solution
Cervicography 35 mm photograph 3% - 5% acetic acid 
solution
Visual Inspection With Magnification
         VIA with magnification (VIAM) uses a magnifying lens  with a built-in light source to 
examine the cervix after application of acetic acid. A small Indonesian  16  evaluation of an 
earlier version of the device (2.5 magnification) indicated that VIAM may achieve sensitivity 
and specificity of over 90 percent in identifying pre-invasive cervical lesions.
          Preliminary findings from an ongoing study in Calcutta, India, indicate that VIAM has a 
sensitivity of 69 percent and specificity of 82 percent.12  It is not yet known whether use of 
magnification offers  a  significant advantage over  VIA, although the potential  for  increased 
specificity is of particular interest.
REPORTING VISUAL INSPECTION FINDINGS
NORMAL
- Smooth, Pink.
- Clear Mucoid Secretion.
- External Os  Central Hole, Round  - Nulliparous         Slit – 
Multipara.
- Atrophic – Post Menopausal.
ABNORMAL
Infection : Hypertrophy.
Ectopy : Redness / Congestion 
Benign Tumour : Irregualr Surface               
            Distortion,simple erosions. (Do not                   
                                                        bleed on touch)
                                                        Cervical polyps.(With smooth  surface)
                                                        Abnormal discharge
                                                        (foul smelling, dirty white greenish)
                                                        Nabothian follicles
Suspicious of Maligancy                lesions that bleeds on touch /
                                             irregular surface,friable growth 
AFTER ACETIC ACID APPLICATION
VIA Positive  Acetowhite areas present
VIA Negative Acetowhite areas not present.
Different categories used to classify results to direct visual inspection
Category Results
Suspicious Cervical ulcer or exophytic 
growth suspicious for 
carcinoma
Definite Lesion Acetowhite lesion with well 
– circumscribed border
Non confluent scattered 
lesion
Focal small, punctuated 
areas of acetowhitening 
III defined lesion Poorly circumstanced and 
faintly acetowhite
No Lesion No acetowhite lesion visible
Negative VILI
- Normal Cervix 
- Polyps: -  Pale areas with no/partial iodine uptake on polyus 
- Leopard skin appearance is associated with T. Vaginalis infection 
- Pepper  like   non  iodine  uptake  areas  are  seen  in  the  squamous 
epithelium away from the squamocolumnar junction.
- Satellite like, non-iodine uptake areas away from the squmocolumnar 
junction.
Positive VILI
The outcome is scored as positive if dense, thick, bright mustard yellow or saffron –
yellow  iodine  non-uptake  areas  are  seen  in  tranformation  zone  close  to  or  abutting 
squmocolumnar junction or when the entire cervix densely yellow.
VILI Positive (Invasive Cancer)
When a frank, nodular, irrgular, ulceroproliferative growth is visible on the 
cervix which turns yellow on application of iodine.
PAP SMEAR
         Pap screening has achieved only moderate levels of sensitivity, however, meaning that a 
low  proportion  of  individuals  with  dysplasia  is  correctly  identified  by  the  test  as  having 
dysplasia.  A recent meta-analysis found that cervical cytology had an overall sensitivity of 51 
percent and a specificity of 98 percent.
        A Costa Rica study found that Pap screening had 78 percent sensitivity and 94 percent 
specificity in identifying atypical squamous cells of unspecified significance.
THE PAPANICOLAOU SMEAR TERMINOLOGY IN CERVICAL 
CYTOLOGY - THE BETHESDA SYSTEM
 
The introduction of evaluation of cellular material from the cervix and vagina for the 
diagnosis of cervical carcinoma is generally attributed to George Papanicolaou
Pap smear nomenclature 9
Papanicolaou
Class system
(1954)
Descriptive
(1968)
CIN 1978
(Cervical intra 
epithelial 
neoplasia)
Bethesda system 
(1988)
Class I -Negative for
malignant cells
Negative Within normal limits
Class II -Inflammatory 
atypia
-Squamous atypia
-Koilocytic atypia Negative
Reactive and 
reparative changes
Atypical squamous 
cells of undetermined 
significance
Class III Mild dysplasia
Moderate 
dysplasia
Severe dysplasia
CIN-I
CIN-II
CIN-III
-Low grade squamous 
Intraepithelial lesion
High grade squamous 
intraepithelial lesion 
(HSIL)
HSIL
Class IV Carcinoma insitu CIN-III HSIL
Class V Invasive carcinoma
Invasive 
carcinoma Invasive carcinoma
BETHESDA SYSTEM FOR REPORTING CERVICAL / VAGINAL 
CYTOLOGIC DIAGNOSIS (2001) REVISION
General Categorization
1) Within Normal limits
2) Benign cellular changes
3) Epithelial cell abnormality
Benign Cellular Changes (BCC)
Infection and reactive or reparative changes are included under the category of BCC
INFECTION (10% OF CASES)
1) Trichomonas vaginalis- Positive predictive value of 40% in an average risk population
2) Candida - Sensitivity of pap smear compared with culture is about 50%
3) Predominance of  coccobacilli  consistent  with the shift  in  vaginal  flora-suggestive of 
bacterial vaginosis.
4) Bacteria morphologically consistent with actinomyces species
They are best recognized on cytological smear by branching gram-positive filaments 
their  presence  is  strongly  associated  with  presence  of  an  intrauterine  contraceptive 
device
5) Amoeba  have  been  found  in  association  with  the  presence  of  an  IUD  which  is 
Eubacterium nodatum which mimics actinomyces
Reparative or reactive changes
Reparative processes are often encountered
1) With estrogen deficiency
2) Surgery
3) Radio therapy
4) Intercourse
5) IUD users     
Epithelial cell abnormality
1) ATYPICAL SQUAMOUS CELLS
- as of undetermined significance (ASC-US)
- as suggestive of a high grade squamous intra epithelial lesion (ASC- H)
2) LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION (LSIL)
LSIL is most prevalent in women in this early reproductive years (16 to 26 years) The 
cytological  abnormal  squamous  cells  that  are  equivalent  in  size  to  a  normal  superficial  or 
intermediate cell. Diagnostic abnormalities include enlargement of the nucleus, irregularity of 
the nuclear membrane and irregular chromatin distribution.
3) HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)
HSIL is most prevalent in women in their mid to late reproductive years  (26 to 48 
years) The cytologic diagnosis of HSIL relies on the presence of abnormal squamous cells that 
are smaller than those seen in LSIL. The average size of a high grade squamous intraepithelial 
lesion  is  equivalent  to  that  of  a  normal  parabasal  cells.  Diagnostic  abnormalities  include 
nuclear  enlargements,  marked  increase  in  nuclear  to  cytoplasmic  ratio,  irregularity  of  the 
nuclear membrane and irregular chromatin distribution.
4) GLANDULAR CELLS
Endometrial cells, Cytologically benign in postmenopausal women.
Atypical glandular cells of undetermined significance
Endo-cervical adenocarcinoma
PAP STAINING PROCEDURE
The slides are removed from the fixative (95% ethyl alcohol and then dehydrated 
by successively transferring them to 
 80% ethyl alcohol 10 dips 
 70 ethyl alcohol 10 dips 
 50% ethyl alcohol 10 dips
 Distilled of filtered Tap water 10 dips
 Harish or Ehrlich haemotoxylin  - 3 to 6 minutes , tap water rinse
 Sodium actate buffer 1-4 quick dips, with  tap water.
 1% saturated acqueous lithium carbonate – 2 min tap water – 4 min
 Orange G staining after immersion in increasing strength of ethyl alcohol 
50% - 70% 80% 95%
 Eosin azure EA 65 after subjecting them to ethyl alcohol ethyl alcohol and 
absolute alcohol
 Xylol essential for microscopic works on smears
CELL COMPONENTS IN A PAP SMEAR
Basal cells - rarely seen except in atrophic vagina. Small round cells with smooth border and a 
central round nucleus
Parabasal cells - uniform round cells with a thick blue or green cytoplasm. Large central round 
nucleus
Intermediate cells -  polyhedral cells with thin semitransparent pink to blue cytoplasm and 
central large vesicular nucleus. A folding or curling tendency of the edges (navicular cells) is 
seen in pregnancy.
Superficial cells - most common and largest epithelial cells in a pap smear. Polyhedral cells 
with a thin homogenous cytoplasm pink to orange (if keratin is present). Nucleus is central and 
pyknotic.
Endocervical ciliated or nonciliated cells, endometrial cells can also be seen depending on the 
site of collection.
Pap smear and cancer screening
Precursor changes in the uterine cervix are dysplasia and carcinoma in situ.  Invasive cervical 
cancer is a slow and predictable process.  Pap smear is a standard effective method of screening for 
malignant cells.
For an accurate interpretation of the smear the sample should be adequate.  Satisfactory smears 
should fulfill-patient and specimen identity, pertinent clinical details, technically good sample 
and proper cellular composition, cervical transformation Zone should be present.
The  most  common  reason  for  an  unsatisfactory  sample  is  scant  cellularity  and  obscuring 
inflammation and blood.
MOUNTING
The slide in mounted and a cover slip affixed
Mounting Material – Canada Balsam
SMEAR INTERPRETATION
Success depends on
1.Excellence of preparation
2.Skill training & application of the interpreter
3.Excellence of Equipment                 
CERVICAL BIOPSY
A cervical  biopsy  is  a  procedure  performed  to  remove  tissue  from  the  cervix  to  test  for 
abnormal or precancerous conditions, or cervical cancer.
There are several types of cervical biopsies. In addition to removing tissue for testing, some of 
these procedures may be used to completely remove areas of abnormal tissue and may also be 
used for treatment of precancerous lesions.
Types of cervical biopsies include:
• Punch biopsy - a surgical procedure to remove a small piece of tissue from the cervix. One 
or more punch biopsies may be performed on different areas of the cervix.
cone biopsy or conization - a surgical procedure that uses a laser or scalpel to remove a large cone-
shaped piece of tissue from the cervix
  SOME OF THE STUDIES OF VISUAL INSPECTION WITH 
ACETIC ACID AND LUGOL’S IODINE
1.Study  conducted  at  department  of  Obstetrics  and  Gynecology,  Fatima  Jinnah  Medical 
College, Lahore involving 501 women for comparison of visual inspection of cervix and Pap 
smear for cervical cancer screening . Of these 156 subjects were positive with VIA (28.96 %) 
while pap smear was positive in 78 cases (14.4%) . The accuracy of VIA was 77.5% compared 
to 52.8% pap smear. They concluded that VIA was more sensitive & highly specific.8
2.  University  of  Zimbabwe/JHPIEGO Cervical  Cancer  Project  conducted  a  study  in  1090 
women to compare VIA with Cytology. They concluded that VIA was highly sensitive and 
could be valuable in detection of precancerous lesions of the cervix but emphasis to increase 
the specificity of VIA was made.31
3.  Department  of  Obstetrics  and  Gynecology,  Maulana Azad Medical  College,  New Delhi 
conducted a study in 400 women to evaluate the efficacy of VIA / Cytology in Cancer cervix 
screen.  They  concluded  that  Visual  inspection  with  acetic  acid  was  very  sensitive  for 
ectocervical lesions and its immediate results help to see and treat at the first visit.34
4.  A study conducted by Department of Obstetrics and Gynecology, Johns Hopkins Medical 
Centre,Baltimore,MD  21224,USA.[  Blumenthal  PD,Gaffikin  L,  Chirenje  ZM,McGrath 
J,Womack  S.Shah  K  using  2199  women  to  detect  cancer  cervix  using  visual  inspection 
methods HPV and Pap smear. It was shown that in countries with limited resources but with the 
capacity for HPV testing, sequential testing involving the use of VIA followed by HPV could 
yield fewer false positives than the use of VIA alone.24
5.  University  Teaching  Hospitals,Yaounde,Cameroon  [Doh  AS,Nkele  NN.  Achu  Essimbi 
F,Essame o, Nkegoum conducted a study of 5010 women of 30-60 years to access the accuracy 
of visual inspection with acetic acid as a screening method for cervical lesions. Positive lesions 
were subjected to biopsy. They concluded that VIA has acceptable test qualities and may in 
low resource settings be implemented as a large scale screening method.8
6. Department of Obstetrics and Gynecology , Cleveland Clinic Foundation conducted a study 
with 1997 women of age 35-45 years to estimate the sensitivity & specificity of VIA and to use 
it as a primary screen for intraepithelial neoplasia. Visual inspection yielded normal results in 
1445 women (72%,) low-grade intraepithelial neoplasia in 525 (26%) high-grade in 21 (1%) 
and cancer cervix in 6 (0.3%) . The sensitivity was 65% for smaller lesion & 89% for larger 
lesions.  They  concluded  that  VIA  can  be  used  as  a  screening  modality  in  developing 
countries.23
7. The  study  conducted  by  Division  of  Cancer  Epidemiology  and  Genetics,  National 
Cancer Institute, Maryland,USA [Jeronimo J, Morales.  Involving 1921 asymptomatic 
women compared the  efficacy of VIA and Pap smear  as a screening modality for 
detecting cancer cervix. They concluded that not only in low-resource settings but also 
in well equipped health centers VIA is a good screening modality.4
8.
SUBJECTS AND METHODS
           
This was a prospective study conducted at Govt. Kasturbha Gandhi hospital, Chennai, at 
the department of obstetrics and gynecology attach to Madras Medical College, from October 
2003 to March 2006.
This study comprised of study subject [n=500] asymtomatic women who were screened 
for  cancer  cervix  using  visual  inspection  with  acetic  acid  and  lugol  iodine  and  papsmear 
cytology. 
INCLUSION CRITERIA  :
1) Non pregnant women 
2) Women with no symptoms like vaginal discharge, pain, ulcers etc
3) Both multi para & nully para
4) Women accompanying the patients and those attending medical Out patient 
department
EXCLUSION CRITERIA:
1) women with symptoms like vaginal discharge,pain,ulcers etc.
2) Pregnant women 
3) women during menstruation 
4) women with intra vaginal medications
VISUAL INSPECTION WITH ACETIC ACID (VIA) & WITH 
LUGOL’S IODINE (VILI)
THE EXAMINATION :
- The procedure is carefully explained to the women, made comfortable and privacy 
ensured. 
- The patient placed in the lithotomy position. 
- Good visualization is ensured.
- Any abnormal findings in the external genitalia is observed and recorded.  
-  Cusco’s speculum inserted into the vagina and the speculum is opened so as to 
get a clear view of cervix.
- Excess mucus or discharge is cleaned with a cotton swab soaked in normal 
saline solution.
-  Any abnormal findings noted.
-  cervix  washed  with  freshly  prepared  5%  acetic  acid  using  a  syringe. 
(Alternatively can be applied with cotton swab) 
- Waited for approximately one minute
-  The cervix  noted for acetowhite areas.
-  Lugol’s Iodine applied  and waited for one minute
-     The cervix inspected for iodine uptake areas  & non uptake  
      areas
- Findings were recorded.
CHARATERSTICS OF VIA / VILI –POSITIVE CASES 
Low grade lesion
Detection of any acetowhite area – VIA 
Detection of any Non iodine takeup areas – VILI.
(A) High Grade Lesion 
Detection  of  well  defind,  opaque  acetowhite  lesions  close  to  or  touching 
squamocolumnar junction.
Detection of dense, thick, bright mustard yellow or saffron yellow iodine non-uptake 
areas in tranformation zone close to abutting the squamocolumnar juction.
REFERRAL PROTOCOL
1. VIA Negative / VILI Negative (Normal cervix) 
Follow-up after 3-5 years according to the decided policy. Advice to come back 
if symptoms develop.
2. VIA Positive / VILI Positive (Abnormal Cervix) 
If Infection is suspected take a swab and send for microbiological analysis.
If signs of infection is present, treat the patient accordingly and re examine.
PAP SMEAR
Timing
• Smears are not collected during the menstrual periods. 
• The patient should not have intravaginal medications / douches 48 hrs before the test 
• Intercourse not recommended on the night before or day of examination
• Post partum smears after 6 to 8 wks to avoid reparative / inflammatory changes 
Precautions
 Lubricants of all types avoided 
 Vaginal examination to be done only after taking smear
Method
 Combination of Ayre’s Spatual and Endocervical brush for sampling endocervix has 
been shown to be more superior. 
 The patient is put in lithotomy position 
 Visualisation of cervix by Cusco’s speculum
 The spatula placed at the level of cervical os and rotated through 360° circle around the 
os maintaining contact with ectocervix
 Optimal sample is held and smeared on the slide.
 Endocervical brush is than inserted into the os and rotated through 180°.  More than 
180° causes bleeding.  The angle of rotation should be parallel to the endocervical canal 
 The sample is rolled on to the slide in the opposite direction to that  which was used for 
collecting  the sample.
 The  quality  of  the  smear  can  be  improved  by  using  spatula  first  followed  by 
endocervical brush because fewer smears will be obscured by blood.
The slide is with fixed with 95% ethyl alcohol – Fixative
PAP REPORTING IN THE HOSPITAL 
1. Normal Studies
2. Inflammatory Pathology
3. Atypical cells / Low grade lesion
4. High grade lesion
CERVICAL BIOPSY
For VIA Positive 172 cases and VIA Negative 50 cases (Control) punch biopsy was taken at 1 or 
several points and sent for histopathological report. The biopsy reporting in our hospital is as follows.
No major lesion detected
1. Inflamatory
2. Mild Dysplasia
3. Moderate dysplasia
4. Severe dysplasia, Carcinoma in situ
5. Invasive Carcinoma
RESULTS AND ANALYSIS
The study was conducted of Govt. Kasturbha Gandhi Hospital for Women & Children, 
Chennai, attach to Madras Medical College during the period October 2003 – March 2006.
500 Patients were included in the study group and the outcome analysed using various 
parameters. The results were subjected to statistical analysis.
 Sample Size – 500
 Visual Inspection with Acetic Acid (VIA), done in all 500 patients.
 Visual Inspection with Lugol’s Iodine (VILI) done in all 500 patients .
 Papsmear cytology was done in  all 500 cases.
 Those  cases  showing  VIA/VILI  Positive  (or)  cytology  positive  were  subjected  to 
cervical biopsy.
 For 50 VIA Negative cases, biopsy was done (as control)
I CHARACTERISTICS OF STUDY GROUP
1) TABLE - 1
AGE DISTIBUTION OF STUDY GROUP
AGE
n= 500
Age(years) <20 21-30 31-40 41-50 51-55
Frequency 12 139 300 40 9
Percent 2.4% 27.8% 60% 8 1.8
- Majority of patients belonged to 30 -40 yrs age group (60%)
ii) TABLE –2
DISTRIBUTION OF SOCIOECONOMIC GROUP - STUDY
n=500
GRADES 2 3 4 5
Frequency 55 117 174 154
Percent 11% 23.4% 34.8% 30.8%
Most of the patients belonged to socioeconomic category 3 (or) 4
iii) TABLE – 3
DISTRIBUTION OF AGE AT MENARCHE-STUDY GROUP
n=500
Age 
(years)
<12  12-14 14-16 >16
Frequency 10 280 20
5
5
Percent 2% 56% 41 1
- 56% of the study group attained menarche by 12-14 years
iv) TABLE – 4
DISTRIBUTION OF AGE AT MARRIAGE – STUDY GROUP
n=500
Age(years
)
15-20 21-25 26-30
Frequency 262 151 87
Percent 52.4% 30.3% 17.3%
Most of the marriages in this study group were around 18-20 years (50%)
iv) TABLE – 5
DISTRIBUTION OF STUDY GROUP ACCORDING TO PARITY
n=500
Parity 1 2 3 4 5
Frequency 32 174 224 53 17
Percentage 6.
4
34.
8
44.
8
10.
6
3.4
   - Most of the patients in this study group belong to the parity group 3 (45%) 
DISTRIBUTION OF AGE  IN THE STUDY GROUP 
{n=500}
                 mean = 36.75      standard deviation = 9.524     n= 500
                                                            
  
SOCIO ECONOMIC STATUS  DISTRIBUTION IN THE 
STUDY GROUP {n=500}
                    
                      No of cases belonging to grade 2     -55 cases
No of cases belonging to grade 3     -117 cases
No of cases belonging to grade 4     -174 cases
No of cases belonging to grade 5     -154 cases
DISTRIBUTION OF PARITY IN THE STUDY GROUP 
{n=500}
PARITY
1
2
3
4
5
                     
                      No of cases having 1 children     -32 cases
No of cases having 2 children           -174 cases
No of cases having 3 children           - 224 cases
No of cases having 4 children     -53 cases
           No of cases having 5 children     -17 cases
DISTRIBUTION OF AGE AT MENARCHE  IN THE 
STUDY GROUP   {n=500}
mean = 13.97   standard deviation = 1.383     n= 500
DISTRIBUTION OF AGE AT MARRIAGE IN THE 
STUDY GROUP    {n=500}
mean = 21.03 standard devation = 3.025   n= 500
II  RESULTS OBTAINED BY SCREENING METHODS
FINDINGS IN VISUAL INSPECTION OF CERVIX WITH ACETIC ACID (VIA) AND 
WITH LUGOL’S IODINE (VILI)
-All patients in the study group (500 cases) underwent direct visualization of cervix, followed 
by visual inspection with acetic acid and Lugols Iodine
VIA &VILI 
+ve
172 
cases
34%
VIA &VILI 
-ve
378 
cases
66%
i) TABLE – 1
AGE WISE DISTRIBUTION
 n=172 (VIA +ve cases)
Age(years) <20 21-30 31-40 41-50 51-55
VIA and 
VILI
positive
3 49 97 20 3
Percent 1.7% 28.4% 56.6 % 11.6% 1.7%
Most of the patients with VIA and VILI +ve belong to age group 31-40 years (56 %)
ii) TABLE – 2
- VILI /VIA RESULTS – SOCIO ECONOMIC STATUS WISE
n=172 (VIA positive cases)
SocioEcon
Status  – 
Grade
2 3 4 5
VIA 
Positive and
VILI 
Positive 
17 35 63 57
cases
Most of the patients with VIA and VILI +ve belong to socio economic group 3 and 4 
iii) TABLE – 3
- VILI / VIA RESULTS – AGE AT MENARCHE / 
                       N=172 (VIA positive cases)
Age 
(years)
<12  12-14 14-16 >16
Frequency 4 100 66 2
Most of the patients with VIA and VILI +ve  attained menarche at 12-14 years 
2). CYTOLOGY (PAP SMEAR) REPORTS:
Pap smear was taken using Ayer’s spatula and endocervical brush in all 500 women.
Cytology Findings Were :
Findings No. of Cases Percentage
No major lesion detected
Inflammatory
LSIL / Atypical
HSIL
266 Cases
222 Cases
8 Cases
4 Cases
(53.2%)
(44.4%)
(1.6%)
(0.8%)
(iii) Biopsy Findings :
Biopsy done in 222 Cases findings were :172 VIA +ve cases 50VIA –ve cases
Findings No. of Cases Percentage
No major lesion detected 125 Cases (56.3%)
Inflammatory
Mild Dysplasia
Moderate dysplasia
Severe dysplasia
Invasive Carcinoma 
93 Cases
2 Cases
2 Cases
0
0
(41.8%)
(0.9%)
(0.9%)
0
0
N=500
0
50
100
150
200
250
300
Normal LSIL/Atypical
CYTOLOGY FINDINGS
No of cases
Percentage
Findings No of cases Percentage
No major lesion detected 266 53.2
inflammatory 222 44.4
LSIL/Atypical 8 1.6
HSIL 4 0.8
020
40
60
80
100
120
140
Normal Mild
Dysplasia
Severe
Dysplasia
BIOPSY FINDINGS(N=222)
No of cases
Percentage
Findings No of cases Percentage
No major lesion detected 125 56.3
Inflammatory 93 41.8
Mild Dysplasia 2 0.9
Moderate Dysplasia 2 0.9
Severe Dysplasia 0 0
Invasive Carcinoma 0 0
COMPARISON STUDIES 
i) VIA WITH BIOPSY
VIA&VILI 
Test 
Results 
Mild 
Dysplasia
Moderate 
dysplasia
Severe 
Dysplasia
Inv 
carcinoma
Inflam No 
major 
lesion 
detected
Total
+ve 1 2 69 100 172
- ve 1 24 25 50
Total 93 125 222
Sensitivity = 98.9%
Specificity = 39.2%
The positive predictive value = 55.8%
The negative predictive value = 98%
False Positive Percentage = 25%
False Negative Percentage = 75%
(ii) CYTOLOGY WITH BIOPSY
Papsmear 
Test 
Results 
Mild 
Dysplasia
Moderate 
dysplasia
Severe 
Dysplasia
Inv 
carcinoma
Inflam No 
major 
lesion 
detected
Total
+ve 
(major 
lesions)
1 2 9 - 12
_ve (  no 
major 
lesions)
1 120 39 160
2 2 129 39 172
sensitivity = 3/4 x 100 = 75%
Specificity = 159/168 x 100 = 94.6%
The positive predictive value = 3/12 x 100 = 25%
The negative predictive value = 159/160 x 100 = 99.3%
False Positive Percentage = 53%
False Negative Percentage = 25%
DISCUSSION
This  prospective,  descriptive  comparative  study  analysis  the  efficacy  of  visual 
inspection  methods   (VIA/VILI)  with  cytology  and  to  choose  VIA and  VILI  as  an  easly 
interpretable low cost but effective method for cancer cervix 
1.  CHARACTERISTICS OF STUDY GROUP
 Most of the were the age group 30 to 40 years (60%)
 Most of the patients where in the socioeconomic  group 3 (23.4% and group 4 (34.8%). 
 Most of the patients attained menarche at 12-14 yrs (50%).
 Most of them got married at 18-20 yrs (60%).
In the cross sectional screening test done in October 1995 to August 1997women attending 
15 primary health center in Zimbabwe  (10,000 study group age group included was 25 to 55 
years the efficacy of VIA and cytology in the study group the mean age was 33.25%.   Most of 
the patients were belonging into status 3.  56% attained menarche at 13 years and most of the 
got married at 18 years (46%).
2. VISUAL INSPECTION FINDINGS-VIA AND VILI
All patients were subjected to visual inspection with acetic and lugo’s iodine.
VIA and VILI positive in 172 cases and in the remaining the test results were negative.
Thus 34% of the screening population showed positive results
The above findings correlated with the study conducted by Shankara Narayanan et al, in 
Kolkatta involving 5881 women which showed VIA positive results in 30% .
Also in another study by Tayyeb etal, VIA was positive in 28.6% of the cases.
PAP SMEAR CYTOLOGY FINDINGS
All patients were subjected to pap smear cytology.
There  were  206  cases  (53.2%)  with  no  detectable  lesion   findings,222  Cases  showed 
inflammatory findings (44.4%),   8 Cases (1.6%) showed LSIL / Atypical changes , 4 cases 
(0.8%) showed HSIL changes in 4 cases 
The 8 cases of LSIL / Atypical group (6 LSIL, 2 Atypical) were subjected to biospy and the 
results were chronic non – specific cervicitis for all of them and they were followed up.
Among the 4 cases of HSIL 1 Cases showed mild dysplasia and two cases moderate dysplasia. 
For the 2 cases of moderate dysplasia the options of less invasive methods like conization and 
large loop excision were given but the two patients were belonging to poor socio economic 
status and coming from a longer distance. Hence the patient could not come for follow up. So 
the patient underwent hysterectomy.  The biopsy results of the 2 of the Two hysterectomy 
specimens were also the same (Moderate Dysplasia).   Case with mild dysplasia was followed 
up. 1 Case of inflammatory finding by Cytology showed mild dysplasia and was followed up.
The above findings were similar to the finding in the study conducted by Belinson J.L. et al. In 1997, 
whose findings were normal (55.2%) inflammatory findings (42.4%), LSIL / Atypical changes (1.4%), 
HSIL (1%)
BIOSPY RESULTS 
Biospy was performed in 222 case(172 VIA +ve cases and 50 VIA –ve cases).  It  showed 
normal findings in 125 cases (56.3%),  inflammatory findings in 93 cases (41.8%), Dysplasia changes 
(mild dysplasia 2 cases – (0.9%), moderate dysplasia (0.9%). There  were  no  cases  of  severe 
dysplasia, carcinoma in situ, invasive carcinoma.
In the study conducted by Longatto filho et al in 2005 involving 10,000 women, the results of 
biospy were 2500 normal cases (54%) 1860 inflammatory (42%), dysplasia in 80 cases (4%) (mild 
dysplasia 2%) moderate dysplasia (2%).  27
 
COMPARISON  OF VIA RESULTS WITH BIOPSY
172  VIA positive cases and 50 VIA negative cases were subjected to biopsy. The  test results 
were calculated and it was found that sensitivity was 98.9% ,specificity was 39.2 %,positive predictive 
value was 55.8% and negative predictive value was 98%.This can be compared with the following 
studies by :
 Blumenthal Pd et al- sensitivity 96%,specificity 60 %,positive predictive value 65%,negative 
predictive value 92% 24
 Singh et al- sensitivity 80%,specificity 60 %,positive predictive value 60%, negative predictive 
value 90% 25
 Siddiqui M et al - sensitivity 60%,specificity 40 %,positive predictive value 65%,      negative 
predictive value 98% 23
 Rajkumar et al,- sensitivity 93.4%,specificity 66 % 31
 Malik N et al - sensitivity 93.%,specificity 30.4 %,positive predictive value 60%,      negative 
predictive value 96% 29
COMPARISON OF PAP SMEAR RESULTS WITH BIOPSY
All VIA positive patients were subjected to Pap smear and biopsy.The sensitivity of pap smear in this 
study was 75%,specificity 94.6 %,positive predictive value 25%,   negative predictive value 96%,false 
positive values 53%, false negative values 25%.
 The above results correlates with  the study by  Bhambani et al where sensitivity was 
76%,specificity 95 %,positive predictive value 25%, negative predictive value 96% 27
 In  another study by Demy et al  sensitivity was 76% , specificity 95 %,positive predictive value 
25%,   negative predictive value 30% 28
Finally when comparing the efficacy of visual inspection studies with acetic acid and lugol’s iodine 
with pap smear cytology:
Sensitivity for VIA was 98.9 %, pap smear cytology 75%
Specificity for VIA was 39.2%, pap smear cytology 94.6%
positive predictive value for VIA 55.8%,   pap smear cytology  25% Negative predictive value 98%, 
pap smear cytology  25%
VIA and VILI has a higher sensitivity than pap smear.The specificity for VIA is less than that 
of pap smear.Hence visual inspection of cervix with acetic acid and lugol’s iodine can be used as an 
alternative strategy to papsmear cytology in a country like ours where adequate cytologists are not 
available. 
SUMMARY
This is the study conducted at Kasturbha Gandhi Hospital for women and children to 
study the efficacy of visual inspection of cervix with acetic acid and lugol’s iodine  in  cervical 
cancer screening  and to use it as an alternative strategy to papsmear in low resource country 
like India.
Totally 500 cases were studied,most of them belonging to 30-40 yrs and socioeconomic 
status 3 0r 4.
172 cases were positive by visual inspection studies (VIA/VILI) almost 30 %.
When these same 172 cases were subjected to biopsy  , 1 case mild dysplasia, 2 cases of 
moderate dysplasia were reported showed .For 50 VIA negative cases biopsy was done and 1 
case showed mild dysplasia and 49 cases were normal.The sensitivity calculated  for visual 
inspection methods were sensitivity 98.9%,specificity 32.9%,positive predictive value 55.8% 
,negative predictive value 98 %.
2 cases of mild dysplasia was followed up and the 2 cases of moderate dysplasia underwent 
hysterectomy and the histopathological findings were also the same.
VIA and biopsy was found significant at  0.000
Among the pap smear cytology results  there were 53.2 % normal finding,44.4 % inflammatory 
finding,1.6 % LSIL/Atypical( 6 cases LSIL ,2  cases Atypical),HSIL 0.8 %( 4 cases).All the 
LSIL  and  Atypical  cases  underwent  biopsy  and  was  found  to  be  chronic  non  specific 
cervicitis.These cases were followed up.The 4 HSIL cases were subjected to biopsy,2 showed 
mild dysplasia,2 moderate dysplasia .
The sensitivity for papsmear in this study was 75%,specificity 94.6%,positive predictive value 
25 %,negative predictive value 99.3 %.
Thus the sensitivity for visual inspection studies was greater than that of papsmear cytology. 
Thus  in  a  low resource  country  like  ours   where  adequate  number  of  cytologists  are  not 
available  visual  inspection with acetic  acid and lugol’s  iodine can be  used as  an effective 
screening technique for cervical cancer.
CONCLUSION
• Visual inspection under Acetic Acid  & Lugol 
• Smple and easy 
• Minimally dependent on infrastructure
• Low startup and sustaining cost 
• Results available immediately
• May be possible to integrate into primary health care 
• Can be done by paramedical trained staff 
• It is  effective and can be used as an alternate strategy in low resource settings 
where  screening  for  cancer  cervix  by  pap smear  is  not  always  possible  due  to 
inadequate cytologists.
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PROFORMA
NAME AGE          OP/IP NO
OCCUPATION
SOCIOECONOMIC STATUS
ADDRESS
AGE AT MENARCHE
AGE AT MARRIAGE
PARITY
LCB
H/O SEXUALLY TRANSMITTED DISEASE
PAST H/O HT/DM/ASTHMA/EPILEPSY/ TB
PAST H/O SURGERY (ABDOMINAL)
CONTRACEPTIVE HISTORY
PERMANENT / TEMPORARY
-STERILISATION:  Puerperal Sterilisation
              Trans abdominal tubectomy –  {Interval  or 
                                     Lap sterilization  concurrent with MTP }
                                     Caesarian section with sterilization
  
GENERAL EXAMINATION
HEIGHT 
WEIGHT
BUILD / NOURISHMENT
ANEMIA JAUNDICE
THYROID BREAST
VITALS SIGNS PULSE RATE BP RESPIRATORY      TEMP
RATE
SYSTEMIC EXAMINATION
CARDIOVASCULAR SYSTEM
RESPIRATORY STYSTEM
ABDOMINAL EXAMINATION
SPECULUM EXAMINATION
VISUAL INSPECTION WITH ACETIC ACID
VISUAL INSPECTION WITH LUGOL’S + IODINE
PAPSMEAR CYTOLOGY
BIOPSY
REPORT
FOLLOW UP ACTION
MASTER CHART
MASTER CHART FOR 500 STUDY CASES
Sl.No Name IP.OP/No Age S/E Status
Age at 
menarche
Age at 
marriage Parity VIA VILI Cytology Biopsy
            
1 Kasthuri 11774 50 4 13 18 4 (+)  ve (+)  ve INFLAM INFLAM
2 Vimala 11723 36 5 15 20 2 (-)  ve (-)  ve INFLAM -
3 Raj Govind 57665 45 3 12 23 2 (-)  ve (-)  ve INFLAM -
4 Sharmila 49962 29 4 16 21 2 (-)  ve (-)  ve NORMAL NORMAL
5 Sumithra 49863 34 4 14 18 2 (-)  ve (-)  ve INFLAM -
6 Vijayalakshmi 48694 34 3 14 25 2 (-)  ve (-)  ve INFLAM -
7 Manimekalai 51960 22 5 12 16 3 (-)  ve (-)  ve NORMAL -
8 Usha 52266 26 5 14 17 2 (-)  ve (-)  ve INFLAM -
9 Saroja 48014 48 3 15 21 2 (-)  ve (-)  ve ATYPICAL INFLAM
10 Paer 51439 32 4 12 18 2 (-)  ve (-)  ve INFLAM -
11 Sarasu 51800 40 5 15 19 5 (+)  ve (+)  ve LSIL INFLAM
12 Jaya 54046 38 2 16 22 2 (-)  ve (-)  ve NORMAL -
13 Shanthi 8462 40 5 15 21 1 (-)  ve (-)  ve NORMAL -
14 Kasthuri 5487 31 4 14 20 3 (-)  ve (-)  ve NORMAL -
15 Idayanthi 56493 35 3 12 18 2 (-)  ve (-)  ve NORMAL NORMAL
16 Manohari 53122 50 4 14 20 1 (+)  ve (+)  ve INFLAM INFLAM
17 Shaila Banu 55469 32 2 14 20 2 (-)  ve (-)  ve NORMAL -
18 Maniam 56779 25 5 15 21 1 (-)  ve (-)  ve NORMAL -
19 Saraswathi 56702 45 4 12 18 3 (-)  ve (-)  ve NORMAL -
20 Jaya chitra 56853 30 2 13 19 1 (+)  ve (+)  ve NORMAL NORMAL
21 Kasthuri 45110 31 3 16 22 2 (+)  ve (+)  ve INFLAM INFLAM
22 Vijayalakshmi 56891 34 4 16 19 4 (+)  ve (+)  ve INFLAM INFLAM
23 Gomathi 56082 30 5 15 21 4 (-)  ve (-)  ve NORMAL -
24 Pilomina 57360 50 3 14 20 3 (-)  ve (-)  ve NORMAL -
25 Shanthi 54865 30 5 12 18 2 (-)  ve (-)  ve NORMAL -
26 Parvathi 56831 30 5 14 20 1 (+)  ve (+)  ve NORMAL INFLAM
27 Sakunthalai 58301 53 4 12 18 2 (-)  ve (-)  ve NORMAL NORMAL
28 Saraswathi 51933 27 3 14 20 3 (-)  ve (-)  ve NORMAL -
29 Assuer Bee 57538 33 4 14 20 1 (+)  ve (+)  ve INFLAM INFLAM
30 Yamuna 54091 20 2 15 15 4 (+)  ve (+)  ve NORMAL NORMAL
31 Kaniga 58899 26 5 12 26 2 (+)  ve (+)  ve NORMAL NORMAL
32 Noorjahan 56944 43 4 13 25 1 (-)  ve (-)  ve NORMAL -
33 Sumathi 59375 43 3 16 16 5 (-)  ve (-)  ve NORMAL -
34 Tamilarasi 57013 42 2 16 17 1 (-)  ve (-)  ve NORMAL NORMAL
35 Pattammal 58291 55 4 15 18 3 (-)  ve (-)  ve NORMAL -
36 Amudha 55966 30 5 14 21 1 (+)  ve (+)  ve NORMAL NORMAL
37 Subbu Lakshmi 57928 30 3 12 18 2 (-)  ve (-)  ve NORMAL -
38 Yamuna 54091 20 4 14 22 3 (-)  ve (-)  ve NORMAL -
39 Hemra 58591 45 5 16 21 1 (-)  ve (-)  ve NORMAL -
40 Haspriyam 58598 35 3 15 20 2 (+)  ve (+)  ve NORMAL NORMAL
41 Siva Kani 57678 28 5 14 18 1 (+)  ve (+)  ve NORMAL NORMAL
42 Girija 60086 35 5 12 20 3 (-)  ve (-)  ve NORMAL NORMAL
43 Sumathi 57472 27 4 13 20 2 (-)  ve (-)  ve NORMAL -
44 Shanthi 8462 36 3 12 21 4 (-)  ve (-)  ve NORMAL -
45 Nirmala 43026 30 3 16 18 2 (-)  ve (-)  ve NORMAL NORMAL
46 Saraswathi 48528 55 4 15 19 1 (+)  ve (+)  ve NORMAL NORMAL
47 Devi 32182 35 2 14 22 3 (-)  ve (-)  ve NORMAL -
48 Sarala 55525 30 5 12 22 1 (-)  ve (-)  ve NORMAL -
49 Saroja 48014 48 4 14 21 2 (+)  ve (+)  ve INFLAM INFLAM
50 Aruna 61371 35 3 12 20 3 (+)  ve (+)  ve NORMAL NORMAL
51 Vasantha 61376 32 4 16 18 4 (-)  ve (-)  ve NORMAL -
52 Vasanthi 61353 45 2 15 20 3 (-)  ve (-)  ve NORMAL -
53 Kuppammal 61346 36 5 14 21 2 (-)  ve (-)  ve NORMAL -
54 Mohana 61357 47 4 12 20 1 (-)  ve (-)  ve NORMAL NORMAL
55 Kasthuri 9480 31 3 14 18 5 (-)  ve (-)  ve NORMAL -
56 Jayanthi 61353 39 5 15 20 3 (+)  ve (+)  ve INFLAM INFLAM
57 Megala 61206 40 4 12 20 1 (-)  ve (-)  ve NORMAL -
58 Anjali 643761 36 5 16 21 2 (-)  ve (-)  ve NORMAL -
59 Mamudha 61307 41 3 15 18 1 (-)  ve (-)  ve NORMAL -
60 Rani 60856 34 5 14 19 2 (+)  ve (+)  ve NORMAL NORMAL
61 Selvi 61329 29 5 12 22 1 (+)  ve (+)  ve NORMAL NORMAL
62 Vasantha 58661 32 4 14 22 3 (-)  ve (-)  ve NORMAL -
63 Gomathi 61390 32 3 12 21 1 (-)  ve (-)  ve NORMAL -
64 Rukmani 61378 55 4 13 20 2 (-)  ve (-)  ve NORMAL -
65 Nirmala 61324 53 4 14 18 3 (-)  ve (-)  ve NORMAL NORMAL
66 Pilomina 57360 50 3 15 20 2 (+)  ve (+)  ve INFLAM INFLAM
67 Devi 61336 39 5 12 18 3 (-)  ve (-)  ve NORMAL -
68 Prema 61328 30 5 16 20 2 (-)  ve (-)  ve NORMAL -
69 Rajeswari 61347 46 4 15 20 1 (-)  ve (-)  ve NORMAL -
70 Malliga 57595 45 4 14 15 2 (+)  ve (+)  ve NORMAL NORMAL
71 Abi Bee 59873 36 3 12 26 3 (+)  ve (+)  ve NORMAL NORMAL
72 Kamini 61373 39 5 14 25 1 (-)  ve (-)  ve NORMAL -
73 Renuka 61325 41 4 12 16 4 (-)  ve (-)  ve NORMAL -
74 Bhuvaneswari 58437 46 5 13 17 2 (-)  ve (-)  ve NORMAL -
75 Poorniammal 61388 29 3 12 18 1 (-)  ve (-)  ve NORMAL NORMAL
76 Rukmani 61313 53 4 16 21 2 (+)  ve (+)  ve NORMAL NORMAL
77 Yamuna 54091 20 5 15 18 5 (+)  ve (+)  ve INFLAM INFLAM
78 Usha 61322 35 5 14 22 1 (-)  ve (-)  ve NORMAL -
79 Sathyam 59841 32 4 12 21 2 (+)  ve (+)  ve INFLAM INFLAM
80 Saroja 61396 39 4 14 20 3 (-)  ve (-)  ve NORMAL -
81 Valliammal 61312 42 4 16 18 4 (+)  ve (+)  ve INFLAM INFLAM
82 Tamilselvi 61178 46 2 15 20 3 (-)  ve (-)  ve NORMAL -
83 Hesperuma 58598 48 5 14 20 2 (-)  ve (-)  ve NORMAL NORMAL
84 Malliga 61151 41 4 12 21 1 (-)  ve (-)  ve NORMAL -
85 Sasi kala 61408 39 3 14 18 2 (-)  ve (-)  ve NORMAL -
86 Meena 61408 42 4 14 19 3 (+)  ve (+)  ve NORMAL NORMAL
87 Saraswathi 61403 51 2 15 22 1 (-)  ve (-)  ve NORMAL -
88 Kanniga 58899 41 5 12 22 4 (+)  ve (+)  ve INFLAM INFLAM
89 Rajeswari 61417 30 4 16 21 2 (-)  ve (-)  ve NORMAL -
90 Devi 61126 36 2 15 20 1 (+)  ve (+)  ve NORMAL NORMAL
91 Fathima 61429 39 3 14 18 2 (+)  ve (+)  ve NORMAL NORMAL
92 Geetha 53642 33 4 12 20 1 (-)  ve (-)  ve NORMAL -
93 Malliga 61455 41 5 14 20 3 (-)  ve (-)  ve NORMAL -
94 Kadar ali Pathima 51259 49 3 14 21 1 (-)  ve (-)  ve NORMAL -
95 Sakunthalai 60595 51 5 15 18 2 (-)  ve (-)  ve NORMAL -
96 Nagammal 61489 46 5 14 19 3 (+)  ve (+)  ve NORMAL NORMAL
97 Poongodi 61412 24 4 12 22 1 (-)  ve (-)  ve NORMAL -
98 Banu 61441 24 3 14 22 2 (-)  ve (-)  ve NORMAL -
99 Indrani 61446 32 4 14 21 5 (+)  ve (+)  ve INFLAM INFLAM
100 Malini 61451 39 2 12 20 3 (+)  ve (+)  ve NORMAL NORMAL
101 Kamala 61245 48 4 16 18 2 (+)  ve (+)  ve INFLAM INFLAM
102 Malar 61488 41 3 15 20 1 (-)  ve (-)  ve NORMAL -
103 Suganthi 61458 52 5 14 21 2 (-)  ve (-)  ve NORMAL -
104 Rani 61452 44 4 12 20 1 (-)  ve (-)  ve NORMAL -
105 Kokila 61463 28 2 14 18 3 (-)  ve (-)  ve NORMAL -
106 Ananthi 60703 29 5 14 20 1 (+)  ve (+)  ve INFLAM INFLAM
107 Pasimalar 61457 43 4 15 20 2 (-)  ve (-)  ve NORMAL NORMAL
108 Prasanna 61466 28 2 12 21 3 (-)  ve (-)  ve NORMAL -
109 Lalitha 61430 20 3 13 18 4 (-)  ve (-)  ve NORMAL -
110 Pattammal 58219 55 4 16 19 5 (+)  ve (+)  ve INFLAM INFLAM
111 Aysha 61485 55 5 16 22 2 (+)  ve (+)  ve INFLAM INFLAM
112 Kindammal 60828 40 3 15 22 1 (-)  ve (-)  ve NORMAL -
113 Selvi 51122 40 5 14 21 2 (-)  ve (-)  ve NORMAL -
114 Rajee 60065 35 5 12 20 3 (-)  ve (-)  ve NORMAL NORMAL
115 Anopselvi 60023 42 5 14 18 1 (-)  ve (-)  ve NORMAL -
116 Amsa 6134 51 4 12 20 2 (+)  ve (+)  ve NORMAL NORMAL
117 Vasanthi 61376 55 3 14 18 1 (-)  ve (-)  ve NORMAL -
118 Kuppammal 61340 56 4 14 20 2 (-)  ve (-)  ve NORMAL -
119 Mehoob 61206 45 2 15 20 1 (-)  ve (-)  ve NORMAL -
120 Rani 60856 42 5 12 15 2 (+)  ve (+)  ve NORMAL NORMAL
121 Amudha 61329 40 4 13 26 4 (+)  ve (+)  ve INFLAM INFLAM
122 Abi Bee 61325 37 3 16 25 3 (-)  ve (-)  ve NORMAL -
123 Krishnammal 61324 41 4 16 16 2 (-)  ve (-)  ve NORMAL -
124 Mala 61452 50 2 15 17 1 (-)  ve (-)  ve NORMAL NORMAL
125 Usha 61384 53 5 14 18 2 (-)  ve (-)  ve NORMAL -
126 Indhu 31452 58 4 12 21 1 (+)  ve (+)  ve NORMAL NORMAL
127 Kondammal 3145 32 2 14 18 3 (-)  ve (-)  ve NORMAL -
128 Shanthi 1254 39 3 16 22 1 (-)  ve (-)  ve NORMAL -
129 Rameesa 13277 43 4 15 21 2 (-)  ve (-)  ve NORMAL -
130 Shanthi 20862 35 5 14 20 3 (+)  ve (+)  ve NORMAL NORMAL
131 Vedha valli 24606 38 3 12 18 2 (+)  ve (+)  ve NORMAL NORMAL
132 Amsa 5152 44 5 13 20 5 (-)  ve (-)  ve NORMAL -
133 Jamathi 5264 52 5 12 20 2 (-)  ve (-)  ve NORMAL -
134 Padmavathi 6063 28 4 16 21 1 (-)  ve (-)  ve NORMAL NORMAL
135 Neelammal 33261 54 3 15 18 2 (+)  ve (+)  ve NORMAL INFLAM
136 Dhana Bakyam 7010 45 4 14 19 3 (+)  ve (+)  ve NORMAL INFLAM
137 Pappa 36806 53 2 12 22 1 (+)  ve (+)  ve NORMAL INFLAM
138 Jasby Raj 36807 58 5 16 22 2 (-)  ve (-)  ve NORMAL -
139 Shanthi 7960 32 3 15 21 1 (-)  ve (-)  ve NORMAL -
140 Gowri 21651 39 3 14 20 2 (+)  ve (+)  ve NORMAL NORMAL
141 Ammeena 21654 41 4 12 18 1 (+)  ve (+)  ve NORMAL INFLAM
142 Saraswathi 46222 36 2 14 20 3 (-)  ve (-)  ve NORMAL -
143 Nirmala 21672 30 5 12 18 5 (+)  ve (+)  ve NORMAL NORMAL
144 Rukmani 43113 47 4 16 21 2 (-)  ve (-)  ve NORMAL -
145 Faisy 41514 47 3 15 18 3 (-)  ve (-)  ve NORMAL NORMAL
146 Lakshmi 45456 48 4 14 22 4 (+)  ve (+)  ve NORMAL INFLAM
147 Chitra Devi 45406 35 2 12 21 3 (-)  ve (-)  ve NORMAL -
148 Jaya lakshmi 49377 34 5 14 20 2 (+)  ve (+)  ve NORMAL INFLAM
149 Valliammal 4912 38 4 14 18 1 (-)  ve (-)  ve NORMAL -
150 Rani 50560 39 3 15 20 2 (+)  ve (+)  ve NORMAL INFLAM
151 Bakya Jyothi 11155 42 5 12 20 3 (+)  ve (+)  ve NORMAL NORMAL
152 Kamakshi 10471 32 4 16 21 1 (-)  ve (-)  ve NORMAL -
153 Chitra 49700 50 5 15 18 4 (-)  ve (-)  ve NORMAL -
154 Malliga 57575 44 3 14 19 5 (+)  ve (+)  ve NORMAL INFLAM
155 Asha 11722 48 5 12 22 1 (+)  ve (+)  ve NORMAL NORMAL
156 Shamin 53204 41 5 14 22 2 (+)  ve (+)  ve INFLAM INFLAM
157 Vijaya 48674 52 4 14 21 1 (-)  ve (-)  ve INFLAM -
158 Kasthuri 46937 44 3 15 20 1 (+)  ve (+)  ve NORMAL NORMAL
159 Gowriammal 46547 28 4 12 18 2 (-)  ve (-)  ve NORMAL NORMAL
160 Janaki 55952 29 4 13 20 3 (-)  ve (-)  ve NORMAL -
161 Devika 52611 43 3 16 20 4 (+)  ve (+)  ve INFLAM INFLAM
162 Kannammal 54361 28 5 16 21 3 (-)  ve (-)  ve NORMAL -
163 Mala 53214 20 5 15 18 2 (-)  ve (-)  ve NORMAL -
164 Chandrakala 53241 22 4 14 19 1 (-)  ve (-)  ve NORMAL -
165 Ananthi 54213 33 4 12 22 5 (+)  ve (+)  ve NORMAL INFLAM
166 Kasthuri 4511 40 3 14 22 3 (+)  ve (+)  ve INFLAM INFLAM
167 Anjali 45715 40 5 12 21 1 (+)  ve (+)  ve NORMAL INFLAM
168 Rani 13552 35 4 16 20 4 (-)  ve (-)  ve NORMAL -
169 Girija 23145 42 5 15 18 2 (-)  ve (-)  ve NORMAL -
170 Rathu 61694 51 3 14 20 1 (-)  ve (-)  ve NORMAL NORMAL
171 Jayalakshmi 63678 55 4 12 21 2 (-)  ve (-)  ve NORMAL -
172 Dhanyu 63678 56 5 14 20 1 (+)  ve (+)  ve NORMAL NORMAL
173 Kalaivani 63415 43 5 14 18 3 (+)  ve (+)  ve INFLAM INFLAM
174 Yamuna 54091 20 4 15 20 1 (+)  ve (+)  ve INFLAM INFLAM
175 Bhavani 53716 27 4 12 20 2 (-)  ve (-)  ve NORMAL -
176 Kondammal 65412 48 4 16 21 4 (+)  ve (+)  ve NORMAL NORMAL
177 Renuka 37908 28 3 15 18 3 (-)  ve (-)  ve NORMAL -
178 Nirmala 43026 30 4 14 19 4 (+)  ve (+)  ve INFLAM INFLAM
179 Siluvai Mary 76447 35 2 12 22 1 (-)  ve (-)  ve NORMAL -
180 Anna poorni 62028 33 5 14 22 3 (-)  ve (-)  ve NORMAL -
181 Manjula 64025 23 4 14 21 2 (-)  ve (-)  ve NORMAL NORMAL
182 Thavamani 63256 37 2 15 20 1 (-)  ve (-)  ve NORMAL -
183 Sathya 64416 38 3 12 18 2 (-)  ve (-)  ve NORMAL -
184 Vasanthi 64445 37 4 13 20 1 (-)  ve (-)  ve INFLAM -
185 Madhavi 60870 25 5 16 18 1 (-)  ve (-)  ve NORMAL -
186 Kala 64528 25 3 16 20 3 (+)  ve (+)  ve INFLAM INFLAM
187 Dhanu 64532 40 5 15 20 5 (+)  ve (+)  ve NORMAL NORMAL
188 Chandra 28871 23 5 14 15 1 (-)  ve (-)  ve NORMAL -
189 Elammal 65421 60 4 12 26 2 (-)  ve (-)  ve NORMAL -
190 Maniammal 63761 44 3 14 25 1 (+)  ve (+)  ve NORMAL NORMAL
191 Vijaya 69812 40 4 12 16 3 (-)  ve (-)  ve NORMAL -
192 Rani 59524 45 2 14 17 1 (-)  ve (-)  ve INFLAM -
193 Kanchana 58610 28 5 14 18 2 (-)  ve (-)  ve NORMAL -
194 Nava Neetham 64766 56 3 15 21 3 (-)  ve (-)  ve NORMAL NORMAL
195 Renuka 63769 40 3 12 18 4 (+)  ve (+)  ve NORMAL INFLAM
196 Sasi kala 62479 45 4 13 22 3 (+)  ve (+)  ve NORMAL INFLAM
197 Brindha 57701 35 2 16 21 2 (-)  ve (-)  ve NORMAL -
198 Nirmala 43026 30 5 16 20 5 (+)  ve (+)  ve NORMAL INFLAM
199 Pachaimmal 43251 42 4 15 18 2 (-)  ve (-)  ve ATYPICAL INFLAM
200 Jaya Mary 65215 35 3 14 20 3 (-)  ve (-)  ve NORMAL -
201 Nirmala 6440 35 4 12 20 1 (-)  ve (-)  ve NORMAL -
202 Vanitha 65217 51 2 14 21 1 (-)  ve (-)  ve INFLAM -
203 Poornima 65392 39 5 16 18 3 (-)  ve (-)  ve NORMAL NORMAL
204 Selvi 64113 37 4 15 19 2 (-)  ve (-)  ve NORMAL -
205 Kalyani 65618 40 3 14 22 1 (-)  ve (-)  ve NORMAL -
206 Renuka 65681 22 5 12 22 2 (-)  ve (-)  ve NORMAL -
207 Kani Mozhi 60230 18 4 13 21 1 (-)  ve (-)  ve NORMAL -
208 Lakshmi 15291 27 5 12 20 3 (-)  ve (-)  ve NORMAL -
209 Kanniammal 55462 55 3 16 18 5 (+)  ve (+)  ve NORMAL INFLAM
210 Anjali 52664 29 5 15 20 2 (+)  ve (+)  ve NORMAL NORMAL
211 Kannammal 65421 35 5 14 20 3 (+)  ve (+)  ve NORMAL NORMAL
212 Devaki 65915 38 4 12 21 4 (-)  ve (-)  ve NORMAL -
213 Kani Mozhi 60230 35 4 14 18 3 (-)  ve (-)  ve NORMAL NORMAL
214 Vasantha 65576 55 5 14 19 2 (-)  ve (-)  ve NORMAL -
215 Selvi 63348 37 3 15 22 1 (-)  ve (-)  ve NORMAL -
216 Mary 51965 35 4 12 22 2 (+)  ve (+)  ve INFLAM INFLAM
217 Anna poorni 62028 29 5 16 21 3 (-)  ve (-)  ve INFLAM -
218 Shanthi 66154 42 5 15 20 1 (-)  ve (-)  ve NORMAL -
219 Shanthini 66153 32 4 14 18 2 (-)  ve (-)  ve NORMAL -
220 Premavathy 63870 50 4 12 20 5 (+)  ve (+)  ve NORMAL INFLAM
221 Revathi 61102 25 4 14 21 2 (+)  ve (+)  ve INFLAM INFLAM
222 Parveen Banu 66171 25 3 14 20 1 (-)  ve (-)  ve NORMAL -
223 Kathun Begam 64751 28 4 15 18 3 (-)  ve (-)  ve NORMAL NORMAL
224 Bhavani 53716 27 2 12 20 1 (+)  ve (+)  ve INFLAM INFLAM
225 Alamelu 7275 30 5 13 20 2 (+)  ve (+)  ve NORMAL INFLAM
226 Munniammal 59939 30 4 16 21 3 (+)  ve (+)  ve INFLAM INFLAM
227 Nava Neetham 66172 21 2 16 18 4 (-)  ve (-)  ve INFLAM -
228 Kannammal 5546 55 3 15 19 3 (-)  ve (-)  ve INFLAM -
229 kalaivani 65386 25 4 14 22 2 (-)  ve (-)  ve NORMAL -
230 Narmadha 75718 21 5 12 22 1 (+)  ve (+)  ve NORMAL INFLAM
231 Meena 68451 50 3 14 21 5 (+)  ve (+)  ve INFLAM INFLAM
232 Yasodha 65619 38 5 12 20 3 (-)  ve (-)  ve NORMAL -
233 Premavathy 63872 56 5 16 18 1 (+)  ve (+)  ve INFLAM INFLAM
234 Sundari 28876 37 4 15 20 4 (-)  ve (-)  ve NORMAL -
235 Subbu lakshmi 65727 33 3 14 18 2 (-)  ve (-)  ve NORMAL NORMAL
236 Amala 65821 35 4 12 20 1 (+)  ve (+)  ve INFLAM INFLAM
237 Dhanushkodi 67048 33 2 14 20 2 (-)  ve (-)  ve NORMAL -
238 Selvi 67010 25 5 14 15 1 (-)  ve (-)  ve NORMAL -
239 Siva Janaki 66868 35 3 15 26 1 (-)  ve (-)  ve NORMAL -
240 Rosi 63282 35 3 12 25 2 (-)  ve (-)  ve NORMAL -
241 Prema 66491 42 4 16 16 3 (+)  ve (+)  ve NORMAL INFLAM
242 Mary 63049 42 2 15 17 4 (+)  ve (+)  ve NORMAL INFLAM
243 Selvi 64759 38 5 14 18 3 (-)  ve (-)  ve NORMAL -
244 Ponkodi 66435 45 4 12 21 2 (-)  ve (-)  ve NORMAL -
245 Jamuna 67223 41 3 14 18 1 (-)  ve (-)  ve NORMAL -
246 Saraswathi 66997 42 4 14 22 2 (-)  ve (-)  ve NORMAL -
247 Selvi 9872 24 2 15 21 3 (-)  ve (-)  ve NORMAL -
248 Rageem 6738 28 5 12 20 1 (-)  ve (-)  ve NORMAL -
249 Jamuna 65016 30 4 13 18 4 (-)  ve (-)  ve NORMAL NORMAL
250 Mohana 65615 21 4 16 20 2 (+)  ve (+)  ve INFLAM INFLAM
251 Amul 67173 47 2 16 20 1 (+)  ve (+)  ve INFLAM INFLAM
252 Vijaya 4449 30 3 15 21 2 (-)  ve (-)  ve NORMAL -
253 Kasthuri 10268 38 4 14 18 5 (+)  ve (+)  ve NORMAL INFLAM
254 Devika 67829 31 5 12 19 3 (-)  ve (-)  ve NORMAL -
255 Ganga 67800 39 3 14 22 1 (-)  ve (-)  ve NORMAL -
256 Punita 46999 28 5 12 22 2 (+)  ve (+)  ve INFLAM INFLAM
257 Ammu 67903 37 5 14 21  (-)  ve (-)  ve NORMAL -
258 Samiya bulla 47947 32 4 14 20  (-)  ve (-)  ve NORMAL -
259 Vimala 65424 29 3 15 18  (-)  ve (-)  ve NORMAL -
260 Selvi 65070 29 4 12 20 1 (+)  ve (+)  ve NORMAL NORMAL
261 Kalayarasi 62912 46 2 13 18 3 (+)  ve (+)  ve NORMAL INFLAM
262 Gowri 68112 25 5 16 20 2 (-)  ve (-)  ve NORMAL NORMAL
263 Vijayalakshmi 68211 40 3 16 20 1 (-)  ve (-)  ve NORMAL -
264 Nirmala 13030 30 3 15 21 4 (-)  ve (-)  ve NORMAL -
265 Vijayalakshmi 8308 70 4 14 18 1 (-)  ve (-)  ve NORMAL -
266 Selvi 68210 30 5 12 19 1 (-)  ve (-)  ve NORMAL -
267 Govindammal 13802 33 3 14 22 3 (-)  ve (-)  ve NORMAL -
268 Aishu 68219 38 5 16 22 2 (-)  ve (-)  ve NORMAL -
269 Yuvarani 68273 20 5 14 21 1 (+)  ve (+)  ve NORMAL NORMAL
270 Deepa 68302 25 4 15 20 2 (-)  ve (-)  ve NORMAL -
271 Velamuthu 67224 23 3 14 18 1 (+)  ve (+)  ve NORMAL NORMAL
272 Meena 68453 50 4 12 20 3 (-)  ve (-)  ve NORMAL -
273 Paapathi 39071 65 2 14 21 1 (-)  ve (-)  ve NORMAL NORMAL
274 Gersi 67310 36 5 14 20 2 (-)  ve (-)  ve NORMAL -
275 Abitha Begam 15464 47 3 12 18 5 (+)  ve (+)  ve  INFLAM
276 Kalaiselvi 69767 28 3 15 20 4 (+)  ve (+)  ve  INFLAM
277 Vijaya 6838 62 4 14 20 3 (-)  ve (-)  ve NORMAL -
278 Krishnaveni 68378 24 2 12 21 2 (-)  ve (-)  ve NORMAL -
279 Selvi 65471 29 5 14 18 1 (+)  ve (+)  ve  INFLAM
280 Ramani 68423 35 4 16 19 2 (-)  ve (-)  ve NORMAL -
281 Vijaya 68352 32 3 15 22 3 (+)  ve (+)  ve  INFLAM
282 Santhi 68607 32 4 14 22 1 (-)  ve (-)  ve NORMAL -
283 Dhanayanthree 68621 37 2 12 21 3 (-)  ve (-)  ve NORMAL -
284 Mary 63041 36 4 14 20 2 (-)  ve (-)  ve NORMAL INFLAM
285 Shanthi 68263 42 5 16 18 1 (-)  ve (-)  ve NORMAL -
286 Saraswathi 48528 55 4 15 20 5 (+)  ve (+)  ve INFLAM INFLAM
287 Nagarjuna 68719 30 5 14 18 1 (-)  ve (-)  ve NORMAL -
288 Sathyanthi 68716 45 4 12 20 3 (-)  ve (-)  ve NORMAL -
289 Vadravathi 68910 42 3 13 20 1 (-)  ve (-)  ve NORMAL NORMAL
290 Femina 65741 45 4 12 15 2 (-)  ve (-)  ve NORMAL -
291 Lidia 68225 45 4 16 26 3 (+)  ve (+)  ve INFLAM INFLAM
292 Mariyammal 69007 30 3 15 25 4 (-)  ve (-)  ve NORMAL -
293 Viji 68996 28 5 14 16 3 (-)  ve (-)  ve NORMAL -
294 Malathi 68995 45 5 12 17 2 (-)  ve (-)  ve NORMAL -
295 Johathi 67471 39 4 16 18 1 (-)  ve (-)  ve NORMAL -
296 Abilakshmi 68284 35 4 15 21 2 (+)  ve (+)  ve NORMAL NORMAL
297 Jothi 12721 35 3 14 18 4 (+)  ve (+)  ve NORMAL INFLAM
298 Rasol Bee 68427 41 5 12 22 1 (-)  ve (-)  ve NORMAL -
299 Jayakool 16511 35 4 14 21 2 (-)  ve (-)  ve ATYPICAL INFLAM
300 Mahtoob 68942 30 5 12 20 1 (-)  ve (-)  ve NORMAL -
301 Mohana 65061 25 3 16 18 2 (-)  ve (-)  ve NORMAL -
302 Naramma 69200 60 4 15 20 1 (-)  ve (-)  ve NORMAL -
303 Janaki 68432 28 5 14 20 3 (-)  ve (-)  ve NORMAL -
304 Lakshmi 69288 20 5 12 21 1 (-)  ve (-)  ve NORMAL -
305 Vasuki 68958 35 4 14 18 2 (-)  ve (-)  ve NORMAL NORMAL
306 Selvi 26319 32 4 14 19 3 (-)  ve (-)  ve NORMAL -
307 Indhu kumari 68394 56 4 15 22 4 (-)  ve (-)  ve NORMAL -
308 Sivakami 16834 31 5 12 22 5 (-)  ve (-)  ve NORMAL -
309 Anjali 16446 25 4 16 21 2 (+)  ve (+)  ve NORMAL NORMAL
310 Manjula 68427 28 5 15 20 1 (+)  ve (+)  ve NORMAL NORMAL
311 Dhanalakshmi 65125 29 3 14 26 2 (+)  ve (+)  ve NORMAL NORMAL
312 Kantha 69751 40 4 12 24 3 (-)  ve (-)  ve NORMAL -
313 Krishnaveni 6985 37 5 14 26 1 (-)  ve (-)  ve NORMAL -
314 kanchana 69951 28 5 14 26 4 (-)  ve (-)  ve NORMAL -
315 Shanthi 69946 30 3 15 27 2 (-)  ve (-)  ve NORMAL -
316 Rajeswari 69961 45 2 12 24 1 (+)  ve (+)  ve NORMAL NORMAL
317 Sumathi 70081 34 4 13 25 2 (-)  ve (-)  ve NORMAL -
318 Gangamma 45543 31 4 16 28 1 (-)  ve (-)  ve NORMAL NORMAL
319 Kalyani 16224 40 5 16 28 5 (+)  ve (+)  ve INFLAM INFLAM
320 Jenifer 71134 26 4 15 27 2 (+)  ve (+)  ve NORMAL NORMAL
321 Badhulla 70135 20 2 14 26 3 (+)  ve (+)  ve NORMAL INLFLAM
322 Saraswathi 70150 33 5 12 24 4 (-)  ve (-)  ve NORMAL -
323 Amala 263168 22 4 14 26 3 (-)  ve (-)  ve NORMAL -
324 Shymala 70140 30 2 12 24 2 (-)  ve (-)  ve NORMAL NORMAL
325 Indrani 70237 34 3 16 28 1 (-)  ve (-)  ve NORMAL -
326 Nilla 70411 40 4 15 27 2 (+)  ve (+)  ve NORMAL NORMAL
327 Samitha 70393 27 5 14 26 3 (-)  ve (-)  ve NORMAL -
328 Aruna 70900 39 3 12 24 1 (-)  ve (-)  ve NORMAL -
329 Jameela 70410 18 5 14 26 4 (-)  ve (-)  ve NORMAL -
330 Lakshmi 70414 34 5 14 26 4 (+)  ve (+)  ve HSIL
MOD.DYSPLA
SIA
331 Kamala 69027 42 4 15 27 1 (+)  ve (+)  ve INFLAM INFLAM
332 Saraswathi 70195 30 3 12 24 2 (-)  ve (-)  ve NORMAL -
333 Pushpa 69197 31 4 16 28 1 (-)  ve (-)  ve NORMAL -
334 Neelammal 65498 50 2 15 27 3 (-)  ve (-)  ve NORMAL NORMAL
335 Gani 64318 23 5 14 26 1 (-)  ve (-)  ve NORMAL -
336 Rajeswari 5117 21 3 12 24 2 (+)  ve (+)  ve NORMAL INFLAM
337 Pushpavalli 1071 36 3 14 26 2 (-)  ve (-)  ve NORMAL -
338 Sumathi 51423 33 4 14 26 1 (-)  ve (-)  ve NORMAL -
339 Ponniammal 68514 28 2 15 27 3 (-)  ve (-)  ve NORMAL -
340 Mahalakshmi 1639 27 5 12 24 1 (+)  ve (+)  ve NORMAL NORMAL
341 Jamuna 69340 30 4 13 25 5 (+)  ve (+)  ve NORMAL INFLAM
342 Alamelu 1249 60 3 16 28 2 (-)  ve (-)  ve NORMAL -
343 Shantha 69441 32 4 16 28 1 (-)  ve (-)  ve NORMAL -
344 Gowri 1040 34 2 15 27 2 (-)  ve (-)  ve NORMAL NORMAL
345 Suseela 976 30 5 14 26 1 (-)  ve (-)  ve NORMAL -
346 Devi 284 26 4 12 24 1 (+)  ve (+)  ve NORMAL INFLAM
347 Shanthi 1477 37 4 14 26 3 (-)  ve (-)  ve NORMAL -
348 Renuka 63769 40 2 12 24 2 (-)  ve (-)  ve NORMAL -
349 Therasa 1609 35 3 14 26 1 (-)  ve (-)  ve NORMAL -
350 Ramani 68423 38 4 14 26 2 (+)  ve (+)  ve NORMAL NORMAL
351 Tharaselvi 2553 24 5 15 27 1 (-)  ve (-)  ve NORMAL -
352 Yamini 2526 31 3 12 24 5 (-)  ve (-)  ve NORMAL -
353 Vimala 253 32 5 13 25 1 (-)  ve (-)  ve NORMAL -
354 Malika 1175 29 5 16 28 2 (-)  ve (-)  ve NORMAL -
355 Geetha 3473 30 4 16 28 3 (-)  ve (-)  ve NORMAL -
356 Kalaiselvi 2548 43 3 15 26 4 (+)  ve (+)  ve NORMAL INFLAM
357 Anjali 1014 32 4 14 25 3 (-)  ve (-)  ve NORMAL NORMAL
358 Mary Joseph 3016 41 2 12 16 2 (-)  ve (-)  ve NORMAL -
359 Chitra 7010 54 5 14 17 1 (-)  ve (-)  ve NORMAL -
360 ramani 1082 35 3 16 18 2 (+)  ve (+)  ve NORMAL NORMAL
361 Malika 3019 37 3 15 21 3 (+)  ve (+)  ve INFLAM INFLAM
362 Bhuvaneswari 313 25 4 14 18 1 (-)  ve (-)  ve NORMAL -
363 Shanthi 3141 50 5 12 22 4 (+)  ve (+)  ve HSIL
MOD.DYSPLA
SIA
364 Asha 3470 21 3 13 21 3 (-)  ve (-)  ve NORMAL -
365 Mariamma 3520 36 5 12 20 2 (-)  ve (-)  ve NORMAL -
366 Selvi 3527 30 5 16 18 1 (+)  ve (+)  ve INFLAM INFLAM
367 Yamuna 2117 23 4 15 20 2 (-)  ve (-)  ve NORMAL -
368 Lakshmi 6547 33 3 14 20 1 (-)  ve (-)  ve NORMAL NORMAL
369 Deepa 290 25 4 12 21 3 (-)  ve (-)  ve NORMAL -
370 Kavitha 12859 30 2 14 18 1 (+)  ve (+)  ve NORMAL NORMAL
371 Revathi 5837 41 5 14 19 2 (+)  ve (+)  ve NORMAL INFLAM
372 Divya 6567 29 3 15 22 3 (-)  ve (-)  ve NORMAL -
373 Lakshmi 435 43 3 12 22 4 (-)  ve (-)  ve NORMAL -
374 Selvi 5900 39 4 16 21 5 (+)  ve (+)  ve NORMAL INFLAM
375 Bharathi 5913 35 5 15 20 2 (-)  ve (-)  ve NORMAL -
376 Vijaya 5949 38 4 14 18 1 (+)  ve (+)  ve NORMAL NORMAL
377 Anjali 52566 37 5 12 20 2 (-)  ve (-)  ve NORMAL -
378 Usharani 2120 29 3 14 18 3 (-)  ve (-)  ve NORMAL -
379 Vasanthi 706 35 4 14 20 1 (-)  ve (-)  ve NORMAL -
380 Chitra 6130 38 5 15 20 2 (+)  ve (+)  ve NORMAL NORMAL
381 Alamelu 6542 35 5 12 21 1 (+)  ve (+)  ve NORMAL NORMAL
382 Jeeva 6336 26 4 13 18 2 (-)  ve (-)  ve NORMAL -
383 Mangamma 6431 22 4 16 19 1 (-)  ve (-)  ve NORMAL -
384 Rani 6428 26 5 16 22 3 (-)  ve (-)  ve NORMAL NORMAL
385 Kalavathy 6673 37 3 15 22 5 (+)  ve (+)  ve NORMAL INFLAM
386 Amudha 6490 38 4 14 21 2 (+)  ve (+)  ve NORMAL NORMAL
387 kala 6587 46 5 12 20 3 (-)  ve (-)  ve NORMAL -
388 Susila 6521 50 3 14 18 4 (-)  ve (-)  ve NORMAL -
389 Jaya 6534 38 5 12 20 3 (-)  ve (-)  ve NORMAL -
390 Kaniga 6493 40 5 16 21 2 (+)  ve (+)  ve NORMAL NORMAL
391 Tamil selvi 338 30 4 15 20 1 (+)  ve (+)  ve NORMAL NORMAL
392 Pappu 6990 35 3 14 18 2 (-)  ve (-)  ve NORMAL -
393 Saraswathi 3214 42 4 12 20 3 (-)  ve (-)  ve NORMAL -
394 Kuppu 5412 30 2 14 20 1 (-)  ve (-)  ve NORMAL -
395 Pushpa 6742 54 5 14 21 4 (-)  ve (-)  ve NORMAL -
396 Nameela 7020 29 4 15 18 5 (+)  ve (+)  ve HSIL
MILDDYSPLA
SIA
397 Devi shree 3625 40 3 12 19 1 (-)  ve (-)  ve NORMAL -
398 Shanthi 7175 34 4 16 22 2 (-)  ve (-)  ve NORMAL NORMAL
399 Santha 65181 38 2 15 22 1 (-)  ve (-)  ve NORMAL INFLAM
400 kalaivani 77 50 5 14 21 1 (+)  ve (+)  ve NORMAL NORMAL
401 Devi 7450 29 4 12 20 2 (+)  ve (+)  ve NORMAL NORMAL
402 Anjali 6749 46 2 14 18 3 (-)  ve (-)  ve NORMAL -
403 Gayathri 6808 31 3 14 20 4 (-)  ve (-)  ve NORMAL -
404 Shyamala 7634 36 4 15 18 3 (-)  ve (-)  ve NORMAL -
405 Kuppammal 6731 55 5 12 20 2 (+)  ve (+)  ve NORMAL NORMAL
406 Mariammal 7712 30 3 13 20 1 (-)  ve (-)  ve NORMAL NORMAL
407 Karuna 4802 31 5 16 15 5 (+)  ve (+)  ve LSIL INFLAM
408 Kalaiammal 8113 62 5 16 26 3 (-)  ve (-)  ve NORMAL -
409 Chinnaponnu 8613 38 4 15 25 1 (-)  ve (-)  ve NORMAL -
410 Saraswathi 8730 25 3 14 16 4 (+)  ve (+)  ve NORMAL NORMAL
411 Revathi 6891 55 4 12 19 2 (+)  ve (+)  ve NORMAL NORMAL
412 Ambika 2251 24 2 14 22 2 (-)  ve (-)  ve NORMAL -
413 Ammu 3652 46 5 16 22 1 (-)  ve (-)  ve NORMAL -
414 Chitra 4125 32 4 14 21 2 (-)  ve (-)  ve NORMAL -
415 Shanthi 7615 30 3 15 20 1 (-)  ve (-)  ve NORMAL NORMAL
416 Kumari 9208 32 2 14 18 1 (+)  ve (+)  ve NORMAL NORMAL
417 Kalaiyarasi 7388 31 4 12 20 2 (-)  ve (-)  ve NORMAL -
418 Selvi 1061 40 5 14 21 5 (+)  ve (+)  ve LSIL INFLAM
419 Alsana 6162 35 3 14 20 4 (-)  ve (-)  ve NORMAL -
420 Magopal 9106 40 4 12 18 3 (+)  ve (+)  ve NORMAL NORMAL
421 Sargunamathy 9509 22 5 15 20 2 (+)  ve (+)  ve NORMAL NORMAL
422 Mangai 1610 43 3 14 20 1 (-)  ve (-)  ve NORMAL -
423 Mullai Kodi 9492 46 5 12 21 2 (-)  ve (-)  ve NORMAL -
424 Kaja lakshmi 9488 39 5 14 18 3 (-)  ve (-)  ve NORMAL -
425 Meha Boobi 9562 32 4 16 19 1 (-)  ve (-)  ve NORMAL NORMAL
426 Lakshmi 6541 43 3 15 22 4 (+)  ve (+)  ve NORMAL NORMAL
427 Sherif Abee 9709 55 3 14 22 2 (-)  ve (-)  ve NORMAL -
428 Jamuna 9715 36 4 12 21 1 (-)  ve (-)  ve NORMAL -
429 Chandra 9521 32 2 14 20 5 (+)  ve (+)  ve NORMAL INFLAM
430 Varalakshmi 8837 35 5 16 18 1 (+)  ve (+)  ve NORMAL NORMAL
431 Mohana 9072 42 4 15 20 3 (+)  ve (+)  ve NORMAL NORMAL
432 Jayalakshmi 8308 53 3 14 18 1 (-)  ve (-)  ve NORMAL -
433 Grazy 8940 32 4 12 20 2 (-)  ve (-)  ve NORMAL -
434 Varalakshmi 10214 30 2 13 20  (-)  ve (-)  ve NORMAL -
435 Mahalakshmi 10229 31 5 12 15  (-)  ve (-)  ve NORMAL NORMAL
436 Nagavalli 10220 32 4 16 26  (+)  ve (+)  ve INFLAM INFLAM
437 Anantha 9058 31 3 15 25 1 (-)  ve (-)  ve NORMAL -
438 Kushboo 8737 40 5 14 16 3 (-)  ve (-)  ve NORMAL -
439 Poongodi 7193 28 4 12 17 2 (-)  ve (-)  ve NORMAL -
440 Renuka 4628 28 5 16 18 5 (+)  ve (+)  ve NORMAL NORMAL
441 Nagammal 8735 43 3 15 21 2 (+)  ve (+)  ve INFLAM INFLAM
442 Padmavathi 8997 38 5 14 18 1 (-)  ve (-)  ve NORMAL -
443 Premaa 10721 31 5 12 22 1 (-)  ve (-)  ve NORMAL -
444 Baby 10766 40 4 14 21 3 (-)  ve (-)  ve NORMAL -
445 Neelavathi 10268 35 3 12 20 2 (-)  ve (-)  ve NORMAL NORMAL
446 Yashoda 9302 38 4 16 18 1 (+)  ve (+)  ve INFLAM INFLAM
447 Suganyaa 60782 32 4 15 20 2 (-)  ve (-)  ve NORMAL -
448 Pichayammal 2795 55 3 14 20 1 (-)  ve (-)  ve NORMAL -
449 Venkatalakshmee 9383 47 5 12 21 3 (-)  ve (-)  ve NORMAL -
450 Selvi 7817 25 5 14 18 1 (+)  ve (+)  ve NORMAL NORMAL
451 Velamuthu 8607 33 4 14 19 5 (+)  ve (+)  ve LSIL INFLAM
452 Chinna Mary 9540 26 4 15 22 3 (-)  ve (-)  ve NORMAL -
453 Musthaary 9854 40 3 12 22 4 (-)  ve (-)  ve NORMAL -
454 Lakshmi 10835 45 5 16 21 3 (-)  ve (-)  ve NORMAL -
455 Fathimaa 10254 30 4 15 20 2 (-)  ve (-)  ve NORMAL -
456 Umaa 6600 28 5 14 26 1 (+)  ve (+)  ve LSIL INFLAM
457 Kuppu 11242 35 3 12 24 2 (-)  ve (-)  ve NORMAL NORMAL
458 Devi 11373 28 4 14 26 3 (-)  ve (-)  ve NORMAL -
459 Govindammal 11255 26 5 14 26 1 (-)  ve (-)  ve NORMAL -
460 Umaa 11340 30 5 15 27 1 (+)  ve (+)  ve NORMAL NORMAL
461 Lakshmi 11099 40 4 12 24 3 (+)  ve (+)  ve INFLAM INFLAM
462 Nagammal 11253 28 4 13 25 5 (+)  ve (+)  ve NORMAL NORMAL
463 Selvi 11435 37 4 16 28 1 (-)  ve (-)  ve NORMAL -
464 Ama 6402 36 2 16 28 2 (-)  ve (-)  ve NORMAL -
465 Ariyaalu devi 9004 32 5 15 27 1 (-)  ve (-)  ve NORMAL -
466 SivaShaanti 3654 30 4 14 26 3 (+)  ve (+)  ve NORMAL NORMAL
467 Sadaanu devi 6541 46 3 12 24 1 (-)  ve (-)  ve NORMAL -
468 Saraswathy 8730 27 4 14 26 2 (-)  ve (-)  ve NORMAL NORMAL
469 Devanai 10495 60 2 12 24 3 (-)  ve (-)  ve NORMAL -
470 Sammpoorana 11426 21 5 16 28 4 (+)  ve (+)  ve NORMAL NORMAL
471 Radha 10730 55 4 15 27 3 (+)  ve (+)  ve INFLAM INFLAM
472 Chandra 5952 34 2 14 26 2 (-)  ve (-)  ve NORMAL -
473 Shalini 122 32 3 12 24 5 (+)  ve (+)  ve HSIL
MILD 
DYSPLASIA+L
3
474 Porvaahi 67731 40 5 14 26 2 (-)  ve (-)  ve NORMAL -
475 Vasanthy 11807 30 3 14 26 3 (-)  ve (-)  ve NORMAL -
476 Malliga 9625 30 5 15 27 1 (+)  ve (+)  ve INFLAM INFLAM
477 Sheela 6987 35 5 12 24 2 (-)  ve (-)  ve NORMAL -
478 Amul 9378 25 4 16 28 1 (-)  ve (-)  ve NORMAL -
479 Diga bai 12601 50 3 15 27 2 (-)  ve (-)  ve NORMAL -
480 Chinna Mary 12001 40 3 15 26 1 (+)  ve (+)  ve NORMAL NORMAL
481 Marriyaal 11088 31 4 14 24 3 (+)  ve (+)  ve NORMAL INFLAM
482 Padmavathi 12722 39 2 12 26 1 (-)  ve (-)  ve NORMAL NORMAL
483 Sakira bai 12085 25 5 14 26 2 (-)  ve (-)  ve NORMAL -
484 Sarala 958 37 4 12 27 4 (+)  ve (+)  ve NORMAL NORMAL
485 Arputham 1277 35 3 14 24 4 (-)  ve (-)  ve NORMAL -
486 Santhi 1125 37 4 14 25 3 (+)  ve (+)  ve INFLAM INFLAM
487 Gracy 11208 20 2 15 28 2 (-)  ve (-)  ve NORMAL -
488 Kalayammal 12900 31 5 12 28 1 (-)  ve (-)  ve NORMAL -
489 Muthulakshmi 11425 40 4 13 27 2 (-)  ve (-)  ve NORMAL -
490 Madana 11426 40 3 16 26 3 (+)  ve (+)  ve NORMAL NORMAL
491 Pathima 11605 27 5 16 24 1 (+)  ve (+)  ve INFLAM INFLAM
492 Padmavathi 12517 32 4 15 26 4 (-)  ve (-)  ve NORMAL -
493 Savithri 10426 30 5 14 24 3 (-)  ve (-)  ve NORMAL NORMAL
494 Lakshmi 13043 32 3 12 26 2 (-)  ve (-)  ve NORMAL -
495 Parimala 13053 35 5 14 26 5 (+)  ve (+)  ve NORMAL NORMAL
496 Gayathri 11607 33 5 16 27 2 (+)  ve (+)  ve INFLAM INFLAM
497 Shylaja 13278 70 4 15 24 1 (-)  ve (-)  ve NORMAL -
498 Harithiammal 9015 30 3 14 25 3 (-)  ve (-)  ve NORMAL -
499 Nagooramma 11821 25 4 12 28 1 (-)  ve (-)  ve NORMAL INFLAM
500 Kamakshi 6469 30 4 13 28 2 (+)  ve (+)  ve NORMAL NORMAL

VIA POSITIVE 
NORMAL CERVIX   WITH   NABOTHANAIN CYSTS (small)
VIA  POSITIVE  LESION
VIA  POSITIVE  LESION 
CERVIX WITH  POLYP PROTRUTING   POLYP THROUGH  OS
VILI POSITIVE
CHRONIC  CERVICITIS 
MUCUS POLYP
VIA POSITIVE LESION
VILI POSITIVE LESION
